Autopsy findings in bone marrow transplantation

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Bone marrow transplantation (BMT) is a critical treatment for hematologic malignancies and aplastic anemia.
• Patients undergoing BMT are susceptible to severe complications, including infections and graft-versus-host disease (GVHD).
• Understanding post-transplant complications is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the pathological findings in patients who died after bone marrow transplantation.
• To identify the causes of mortality and significant complications, including neutropenic enterocolitis, cytomegaloviral (CMV) infection, and GVHD.
• To evaluate the potential role of conditioning regimens in BMT-related complications.

Main Methods:

• Autopsy examination of 9 patients (2 aplastic anemia, 7 acute leukemia) who died after BMT.
• Histopathological analysis to identify specific pathologies such as neutropenic enterocolitis, CMV infection, and GVHD.
• Correlation of findings with clinical data, including engraftment status and conditioning regimen.

Main Results:

• Neutropenic enterocolitis was observed in 2 of 3 early deaths before engraftment, linked to conditioning regimen toxicity and neutropenia.
• Cytomegaloviral (CMV) infection was prevalent in engrafted patients, manifesting as pneumonia, hepatitis, enteritis, or disseminated disease.
• Graft-versus-host disease (GVHD) was identified in 4 engrafted patients, with distinct histological features in skin and liver, though challenging to differentiate from CMV in the bowel.
• Interstitial pneumonia had diverse causes, including CMV and potential radiation/cytotoxic drug effects.

Conclusions:

• Neutropenic enterocolitis, CMV infection, and GVHD are significant post-BMT complications.
• Histological differentiation between CMV and GVHD can be challenging, particularly in the gastrointestinal tract.
• Modifying conditioning regimens may mitigate tissue damage and reduce the incidence of these adverse events.